Search

Your search keyword '"Rees, David"' showing total 38 results

Search Constraints

Start Over You searched for: Author "Rees, David" Remove constraint Author: "Rees, David" Language undetermined Remove constraint Language: undetermined
38 results on '"Rees, David"'

Search Results

1. Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis

2. Emerging drug targets for sickle cell disease: shedding light on new knowledge and advances at the molecular level

3. The pleiotropic effects of α-thalassemia on HbSS and HbSC sickle cell disease: Reduced erythrocyte cation co-transport activity, serum erythropoietin, and transfusion burden, do not translate into increased survival

4. sj-docx-1-aln-10.1177_11771801221119266 – Supplemental material for Applying the complementary knowledge bases of System Dynamics and Indigenous knowledge in public health research in Aotearoa, New Zealand

5. sj-pdf-1-jcb-10.1177_0271678X211072391 - Supplemental material for Venous cerebral blood flow quantification and cognition in patients with sickle cell anemia

6. sj-pdf-1-jcb-10.1177_0271678X211072391 - Supplemental material for Venous cerebral blood flow quantification and cognition in patients with sickle cell anemia

7. On dynamical ordering in a 2D electron crystal confined in a narrow channel geometry

8. Additional file 1 of The association between silica exposure, silicosis and tuberculosis: a systematic review and meta-analysis

9. Recommendations regarding splenectomy in hereditary hemolytic anemias

10. Oxidative stress and haemolytic anaemia in dogs and cats: a comparative approach

11. Oxidative stress and phosphatidylserine exposure in red cells from patients with sickle cell anaemia

12. High body mass index in children with sickle cell disease- a retrospective single-centre audit

15. Additional file 2: of Prevention of Morbidity in sickle cell disease - qualitative outcomes, pain and quality of life in a randomised cross-over pilot trial of overnight supplementary oxygen and auto-adjusting continuous positive airways pressure (POMS2a): study protocol for a randomised controlled trial

16. Additional file 1: of Prevention of Morbidity in sickle cell disease - qualitative outcomes, pain and quality of life in a randomised cross-over pilot trial of overnight supplementary oxygen and auto-adjusting continuous positive airways pressure (POMS2a): study protocol for a randomised controlled trial

22. Explore: A Prospective, Multinational Natural History Study of Patients with Acute Hepatic Porphyrias (AHP) with Recurrent Attacks

23. TWENTY-YEAR FOLLOW-UP OF PATIENTS WITH HEMOGLOBIN E THALASSEMIA IN SRI LANKA

24. EXPERIENCE WITH THE IRON-CHELATOR DEFERASIROX IN SRI LANKAN PATIENTS WITH THALASSEMIA

25. ENVISION, A PHASE 3 STUDY OF SAFETY AND EFFICACY OF GIVOSIRAN, AN INVESTIGATIONAL RNAi THERAPEUTIC, IN ACUTE HEPATIC PORPHYRIA PATIENTS

27. EXPLORE: A PROSPECTIVE, MULTINATIONAL NATURAL HISTORY STUDY OF PATIENTS WITH ACUTE HEPATIC PORPHYRIA WITH RECURRENT ATTACKS

28. Explore: A Prospective, Multinational Natural History Study of Acute Hepatic Porphyria Patients with Recurrent Attacks

29. LINEAR GROWTH IN PATIENTS WITH THALASSEMIA MAJOR IN SRI LANKA

32. EXPLORE: A Prospective, Multinational Natural History Study of Patients with Acute Hepatic Porphyria (AHP) with Recurrent Attacks

33. Twelve-Month Interim Analysis of Efficacy and Safety of Givosiran, an Investigational RNAi Therapeutic for Acute Hepatic Porphyria, in the ENVISION Open Label Extension

34. EXPLORE: A prospective, multinational natural history study of acute hepatic porphyria patients with recurrent attacks

36. Mapping the wind in the polar thermosphere a case study within the CEDAR Program

37. The erythrocyte membrane properties of beta thalassaemia heterozygotes and their consequences for Plasmodium falciparum invasion

38. Heteroditopic P,N ligands in gold(I) complexes: Synthesis, structure and cytotoxicity

Catalog

Books, media, physical & digital resources